3. In regulation 3(2) of the Genetically Modified Organisms (Risk Assessment) (Records and Exemptions) Regulations 1996—
(a)in sub-paragraph (c), for the words from “for human or veterinary use” to the end substitute “which is authorised for marketing under the Human Medicines Regulations 2012(1) or the Veterinary Medicines Regulations 2013(2)”;
(b)for sub-paragraph (d) substitute—
“(d)consist of, or are included in, a product which has marketing consent immediately before exit day under Directive 90/220/EEC on the deliberate release into the environment of genetically modified organisms(3) or Directive 2001/18/EC on the deliberate release into the environment of genetically modified organisms(4)—
(i)which is imported or acquired in accordance with the conditions and limitations on the use of the product specified in the consent, and
(ii)in the case of a consent for genetically modified carnations (Dianthus caryophyllus), where the product is imported or acquired within 10 years of the date on which the consent was issued;”.
S.I. 2012/1916, amended by S.I. 2013/235, 1855, 2593, 2014/323, 324, 490, 1878, 2015/178, 259, 354, 903, 1503, 1862, 1879, 2016/186, 190, 696, 2017/715, 1322, 2018/199, 378.
S.I. 2013/2033, amended by S.I. 2014/599, 2018/761.
OJ No L 117, 8.5.1990, p. 15, as last amended by Commission Directive 97/35/EC (OJ No L 169, 27.6.1997, p. 72).
OJ No L 106, 17.4.2001, p. 1, as last amended by Commission Directive (EU) 2018/350 (OJ No L 67, 9.3.2018, p. 30).